OKYO Pharma Statistics
Total Valuation
OKYO Pharma has a market cap or net worth of $55.17 million. The enterprise value is $53.34 million.
| Market Cap | 55.17M |
| Enterprise Value | 53.34M |
Important Dates
The next estimated earnings date is Tuesday, August 13, 2024, before market open.
| Earnings Date | Aug 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OKYO Pharma has 33.24 million shares outstanding.
| Shares Outstanding | 33.24M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 25.72% |
| Owned by Institutions (%) | 2.70% |
| Float | 13.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.72
| Current Ratio | 0.72 |
| Quick Ratio | 0.64 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -136.39 |
Financial Efficiency
Return on equity (ROE) is -2,968.50% and return on invested capital (ROIC) is -8,146.58%.
| Return on Equity (ROE) | -2,968.50% |
| Return on Assets (ROA) | -279.30% |
| Return on Capital (ROIC) | -8,146.58% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.66M |
| Employee Count | 8 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -12,202 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +30.71% in the last 52 weeks. The beta is -3.30, so OKYO Pharma's price volatility has been lower than the market average.
| Beta (5Y) | -3.30 |
| 52-Week Price Change | +30.71% |
| 50-Day Moving Average | 1.38 |
| 200-Day Moving Average | 1.55 |
| Relative Strength Index (RSI) | 70.22 |
| Average Volume (20 Days) | 28,964 |
Short Selling Information
The latest short interest is 39,718, so 0.12% of the outstanding shares have been sold short.
| Short Interest | 39,718 |
| Short Previous Month | 42,516 |
| Short % of Shares Out | 0.12% |
| Short % of Float | 0.29% |
| Short Ratio (days to cover) | 3.88 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -13.19M |
| Pretax Income | -13.28M |
| Net Income | -13.27M |
| EBITDA | -13.18M |
| EBIT | -13.19M |
| Earnings Per Share (EPS) | -$0.61 |
Balance Sheet
The company has $4.05 million in cash and $2.22 million in debt, giving a net cash position of $1.83 million or $0.06 per share.
| Cash & Cash Equivalents | 4.05M |
| Total Debt | 2.22M |
| Net Cash | 1.83M |
| Net Cash Per Share | $0.06 |
| Equity (Book Value) | -2.05M |
| Book Value Per Share | -0.06 |
| Working Capital | -2.06M |
Cash Flow
In the last 12 months, operating cash flow was -$7.70 million and capital expenditures -$5,916, giving a free cash flow of -$7.70 million.
| Operating Cash Flow | -7.70M |
| Capital Expenditures | -5,916 |
| Free Cash Flow | -7.70M |
| FCF Per Share | -$0.27 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OKYO Pharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -29.71% |
| Shareholder Yield | -29.71% |
| Earnings Yield | -24.06% |
| FCF Yield | -13.96% |
Analyst Forecast
The average price target for OKYO Pharma is $7.00, which is 321.69% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.00 |
| Price Target Difference | 321.69% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |